Biosynex Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
273
- Stock Symbol
-
ALBIO
- Investments
-
23
- Share Price
-
$0.91
- (As of Friday Closing)
Biosynex General Information
Description
Biosynex SA develops, manufactures and markets in-vitro diagnostic devices and healthcare products. Its diagnostic portfolio includes rapid diagnostic tests, molecular biology kits, self-tests, immunoblot and point-of-care diagnostic solutions used for screening, diagnosis and patient monitoring. The company provides products for healthcare professionals as well as general-public and pharmacy markets in France and internationally.
Contact Information
Website
www.biosynex.comCorporate Office
- 22 Boulevard Sébastien Brant
- 67400 Illkirch-Graffenstaden
- France
Corporate Office
- 22 Boulevard Sébastien Brant
- 67400 Illkirch-Graffenstaden
- France
Biosynex Stock Performance
As of 13-Nov-2026, Biosynex’s stock price is $0.91. Its current market cap is $16.7M with 18.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.91 | $0.91 | $0.53 - $1.85 | $16.7M | 18.4M | 22K | -$4.55 |
Biosynex Financials Summary
As of 31-Dec-2025, Biosynex has a trailing 12-month revenue of $107M.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 74,316 | 74,316 | 72,906 | 133,095 |
| Revenue | 107,379 | 107,379 | 109,473 | 100,609 |
| EBITDA | (1,913) | (1,913) | (19,363) | (23,425) |
| Net Income | (65,677) | (65,677) | (46,891) | (39,978) |
| Total Assets | 160,034 | 160,034 | 202,587 | 267,207 |
| Total Debt | 72,409 | 72,409 | 65,168 | 72,917 |
Biosynex Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biosynex Comparisons
Industry
Financing
Details
Biosynex Competitors (14)
One of Biosynex’s 14 competitors is Kypha, a Venture Capital-Backed company based in Saint Louis, MO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kypha | Venture Capital-Backed | Saint Louis, MO | ||||
| HemoCue | Corporate Backed or Acquired | Ängelholm, Sweden | ||||
| Lumos Diagnostics Holdings | Formerly VC-backed | Carlsbad, CA | ||||
| Cambridge Clinical Laboratories | Formerly VC-backed | Cambridge, United Kingdom | ||||
| comPLEX Dx | Accelerator/Incubator Backed | Alexandria, VA |
Biosynex Patents
Biosynex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3149970-A1 | Method of controlling a thermometer | Inactive | 16-Jun-2023 | ||
| WO-2024038228-A1 | Device for taking a sample of biological material and comprising a pusher element | Inactive | 19-Aug-2022 | ||
| CA-212809-S | Charging holder for medical thermometer | Active | 25-Oct-2021 | ||
| CA-212807-S | Medical thermometer | Active | 25-Oct-2021 | ||
| CA-212808-S | Thermometer [including medical thermometer] with its charging holder | Active | 25-Oct-2021 |
Biosynex Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biosynex Investments & Acquisitions (23)
Biosynex’s most recent deal was a Merger/Acquisition with ProciseDx. The deal was made on 09-Jun-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ProciseDx | 09-Jun-2023 | Merger/Acquisition | Diagnostic Equipment | ||
| Innoxa Laboratories (Eye Care Activity) | 08-Jun-2023 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Chembio Diagnostic Systems | 27-Apr-2023 | Merger/Acquisition | Diagnostic Equipment | ||
| Biosynex Iberica | 23-Mar-2023 | Merger/Acquisition | Distributors (Healthcare) | ||
| TheraDiag | 31-Jan-2023 | Merger/Acquisition | Diagnostic Equipment |
Biosynex ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Biosynex Affiliates
Subsidiaries (11)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Biosynex Pharma Benelux | Saint-Josse-Ten-Noode, Belgium | 2022 | |
| Doc2U | Toulouse, France | 2020 | |
| ProciseDx | San Diego, CA | 2019 | |
| Enalees | Evry, France | 2015 | |
| Avalun | Grenoble, France | 2013 |
Biosynex FAQs
-
When was Biosynex founded?
Biosynex was founded in 2005.
-
Where is Biosynex headquartered?
Biosynex is headquartered in Illkirch-Graffenstaden, France.
-
What is the size of Biosynex?
Biosynex has 273 total employees.
-
What industry is Biosynex in?
Biosynex’s primary industry is Diagnostic Equipment.
-
Is Biosynex a private or public company?
Biosynex is a Public company.
-
What is Biosynex’s stock symbol?
The ticker symbol for Biosynex is ALBIO.
-
What is the current stock price of Biosynex?
As of 13-Nov-2026 the stock price of Biosynex is $0.91.
-
What is the current market cap of Biosynex?
The current market capitalization of Biosynex is $16.7M.
-
What is Biosynex’s current revenue?
The trailing twelve month revenue for Biosynex is $107M.
-
Who are Biosynex’s competitors?
Kypha, HemoCue, Lumos Diagnostics Holdings, Cambridge Clinical Laboratories, and comPLEX Dx are some of the 14 competitors of Biosynex.
-
What is Biosynex’s annual earnings per share (EPS)?
Biosynex’s EPS for 12 months was -$4.55.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
